994951372	994951372	CD	B-NP	O
|	|	NN	I-NP	O
CMHMC	CMHMC	NN	I-NP	O
|	|	NN	I-NP	O
55458020	55458020	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5912058	5912058	CD	B-NP	O
|	|	CC	I-NP	O
2/7/2006	2/7/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
WEAKNESS	WEAKNESS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2006	7/15/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/2/2006	6/2/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
POROWSKI	POROWSKI	NN	B-NP	O
,	,	,	O	O
JARROD	JARROD	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Failure	Failure	NN	B-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Marfan	Marfan	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
migraine	migraine	NN	B-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
dissection	dissection	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
opioid	opioid	JJ	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
Marfan	Marfan	NNP	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
VNA	VNA	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
worried	worry	VBN	I-VP	O
about	about	IN	B-PP	O
her	her	PRP	B-NP	O
declining	decline	VBG	B-VP	O
clinical	clinical	JJ	B-NP	O
picture	picture	NN	I-NP	O
including	include	VBG	B-PP	O
lethargy	lethargy	NN	B-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
conjunction	conjunction	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
PCP	PCP	NN	I-NP	O
to	to	TO	B-VP	O
admit	admit	VB	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hip	hip	NN	I-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
as	as	IN	B-PP	O
sciatic	sciatic	JJ	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
Hsumbea	Hsumbea	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
opioid	opioid	JJ	B-NP	O
addiction	addiction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
psychiatry	psychiatry	NN	I-NP	O
team	team	NN	I-NP	O
there	there	RB	B-ADVP	O
who	who	WP	B-NP	O
thought	think	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
significant	significant	JJ	B-NP	O
anxiety	anxiety	NN	I-NP	O
components	component	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
there	there	RB	B-ADVP	O
on	on	IN	B-PP	O
suboxone	suboxone	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
given	give	VBN	B-VP	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
less	less	JJR	B-NP	O
potential	potential	NN	I-NP	O
for	for	IN	B-PP	O
abuse	abuse	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
using	use	VBG	I-VP	O
fentanyl	fentanyl	NN	B-NP	O
patches	patch	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Marfan	Marfan	NNP	B-NP	O
syndrome	syndrome	NN	I-NP	O
with	with	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	JJ	B-ADJP	O
post	post	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacements	replacement	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
St.	St.	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
valve	valve	NNP	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
migraines	migraine	NNS	B-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
subdural	subdural	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
and	and	CC	I-NP	O
2002	2002	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
radiologic	radiologic	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
left-sided	left-sided	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
dissection	dissection	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
,	,	,	O	O
glaucoma	glaucoma	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
subdural	subdural	JJ	B-NP	O
evacuation	evacuation	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

EV	EV	NN	B-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Clarinex	Clarinex	NNP	B-NP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Duragesic	Duragesic	JJ	B-NP	O
patch	patch	NN	I-NP	O
12	12	CD	I-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	O
weekly	weekly	RB	B-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
With	With	IN	B-PP	O
Codeine	Codeine	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lidoderm	Lidoderm	NNP	B-NP	O
,	,	,	O	O
MS	MS	NNP	B-NP	O
Contin	Contin	NNP	I-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
oxybutynin	oxybutynin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Tobacco	Tobacco	NNP	B-NP	O
use	use	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
about	about	IN	B-PP	O
14	14	CD	B-NP	O
years	year	NNS	I-NP	O
two	two	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recreational	recreational	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Marfan	Marfan	NNP	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
mild	mild	JJ	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sibling	sibling	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sister	sister	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Contact	Contact	NN	B-NP	O
information	information	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
sister	sister	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
e-mail	e-mail	JJ	I-NP	O
address	address	NN	I-NP	O
lzoctclx	lzoctclx	NN	I-NP	O
@	@	NN	I-NP	O
aeo.pqf	aeo.pqf	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Tetracycline	Tetracycline	NN	B-NP	O
analogs	analog	NNS	I-NP	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
nitrofurantoin	nitrofurantoin	NN	B-NP	O
unknown	unknown	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
ampicillin	ampicillin	NN	B-NP	O
unknown	unknown	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
quinidine	quinidine	NN	B-NP	O
unknown	unknown	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
excessive	excessive	JJ	I-NP	O
somnolence	somnolence	NN	I-NP	O
,	,	,	O	O
sulfa	sulfa	NN	B-NP	O
drug	drug	NN	I-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
erythromycins	erythromycin	VBZ	B-VP	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
hives	hive	NNS	I-NP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
taken	take	VBN	I-VP	O
ampicillin	ampicillin	NN	B-NP	O
without	without	IN	B-PP	O
trouble	trouble	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
68	68	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90/60	90/60	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
talkative	talkative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
moist	moist	JJ	B-ADJP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
small	small	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
was	be	VBD	B-VP	O
flaky	flaky	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
ridging	ridge	VBG	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_type
nails	nail	NNS	I-NP	I-cell_type
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORIES	LABORATORIES	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
142	142	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
93	93	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
23	23	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.7	8.7	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
85	85	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
88	88	CD	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
bili	bili	NNP	I-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
4.0	4.0	CD	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-DNA
36	36	CD	I-NP	I-DNA
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
2.1	2.1	CD	I-NP	I-protein
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
7.8	7.8	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
34.6	34.6	CD	I-NP	I-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	JJ	I-NP	O
moderate-to-severe	moderate-to-severe	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
tortuous	tortuous	JJ	B-NP	O
aorta	aorta	NN	I-NP	O
,	,	,	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
parenchymal	parenchymal	JJ	I-NP	O
opacification	opacification	NN	I-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
faint	faint	NN	I-NP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
was	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
vessel	vessel	NN	B-NP	O
crowd/atelectasis	crowd/atelectasis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
Consults	Consult	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Wittler	Wittler	NNP	I-NP	O
,	,	,	O	O
e-mail	e-mail	JJ	B-NP	O
address	address	NN	I-NP	O
qdwgql	qdwgql	NN	I-NP	O
@	@	NN	I-NP	O
wnzlnued.fvf	wnzlnued.fvf	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
phone	phone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
688-147-0749	688-147-0749	CD	B-NP	O
.	.	.	O	O

Ga	Ga	NNP	B-NP	O
Woodri	Woodri	NNP	I-NP	O
Health	Health	NNP	I-NP	O
beeper	beeper	NN	I-NP	O
is	be	VBZ	B-VP	O
94654	94654	CD	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
psychiatry	psychiatry	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
contact	contact	NN	I-NP	O
person	person	NN	I-NP	O
is	be	VBZ	B-VP	O
Herb	Herb	NNP	B-NP	O
Safa	Safa	NNP	I-NP	O
.	.	.	O	O

Can	Can	MD	B-VP	O
be	be	VB	I-VP	O
paged	page	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
Cockebi-erd	Cockebi-erd	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
paging	page	VBG	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
or	or	CC	O	O
minus	minus	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
narcotic	narcotic	JJ	B-NP	O
addiction	addiction	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
detox	detox	NN	I-NP	O
at	at	IN	B-PP	O
Saddpeace	Saddpeace	NNP	B-NP	O
and	and	CC	O	O
likely	likely	JJ	B-NP	O
abused/overuse	abused/overuse	NN	I-NP	O
of	of	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
her	her	PRP	B-NP	O
without	without	IN	B-PP	O
using	use	VBG	B-VP	O
narcotics	narcotic	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
,	,	,	O	O
tramadol	tramadol	NN	B-NP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zyprexa	Zyprexa	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/27/06	10/27/06	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
fell	fall	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
hit	hit	VB	B-VP	O
her	her	PRP$	B-NP	O
head	head	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bed/commode	bed/commode	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
remember	remember	VB	I-VP	O
the	the	DT	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x2	x2	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
,	,	,	O	O
infarct	infarct	NN	B-NP	O
,	,	,	O	O
mass	mass	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
midline	midline	NN	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
mild-to-moderate	mild-to-moderate	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
and	and	CC	I-NP	O
involutional	involutional	JJ	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
craniotomy	craniotomy	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

Slight	Slight	JJ	B-NP	O
asymmetry	asymmetry	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sulci	sulcus	NNS	I-NP	O
versible	versible	JJ	B-ADJP	O
since	since	IN	B-PP	O
7/25	7/25	CD	B-NP	O
.	.	.	O	O

Ventricles	Ventricle	NNS	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
and	and	CC	O	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
neurology	neurology	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
continuing	continue	VBG	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
her	her	PRP$	B-NP	O
neurological	neurological	JJ	I-NP	O
exam	exam	NN	I-NP	O
checking	check	VBG	B-VP	O
a	a	DT	B-NP	O
lipid	lipid	NN	I-NP	O
profile	profile	NN	I-NP	O
and	and	CC	O	O
involving	involve	VBG	B-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
their	their	PRP$	B-NP	O
neuro	neuro	NN	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
affect	affect	NN	I-NP	O
,	,	,	O	O
slow	slow	JJ	B-NP	O
procity	procity	NN	I-NP	O
and	and	CC	I-NP	O
tone	tone	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
tendency	tendency	NN	I-NP	O
to	to	TO	B-VP	O
loose	loose	VB	I-VP	O
her	her	PRP$	B-NP	O
chain	chain	NN	I-NP	O
of	of	IN	B-PP	O
thought	thought	NN	B-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

4/5	4/5	CD	B-NP	O
weakness	weakness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
quad	quad	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
hamstrings	hamstring	NNS	I-NP	O
muscles	muscle	NNS	I-NP	O
otherwise	otherwise	RB	B-NP	O
5/5	5/5	CD	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Upgoing	Upgoe	VBG	B-VP	O
toe	toe	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
and	and	CC	O	O
muted	mute	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
reflexes	reflexe	VBZ	B-VP	O
2	2	CD	B-NP	O
throughout	throughout	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
sensation	sensation	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
psych	psych	NN	I-NP	O
service	service	NN	I-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
,	,	,	O	O
appearance	appearance	NN	B-NP	O
,	,	,	O	O
behavior	behavior	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
Appearance	Appearance	NN	B-NP	O
and	and	CC	I-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
disheveled	dishevel	VBN	I-VP	O
wearing	wear	VBG	B-VP	O
hospital	hospital	NN	B-NP	O
gown	gown	NN	I-NP	O
,	,	,	O	O
supine	supine	NN	B-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
calm	calm	NN	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
PMR	PMR	NN	I-NP	B-protein
.	.	.	O	O

Speech	Speech	NN	B-NP	O
was	be	VBD	B-VP	O
slow	slow	JJ	B-ADJP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
volume	volume	NN	I-NP	O
and	and	CC	I-NP	O
tone	tone	NN	I-NP	O
.	.	.	O	O

Mood	Mood	NN	B-NP	O
was	be	VBD	B-VP	O
euthymic	euthymic	JJ	B-ADJP	O
.	.	.	O	O

Affect	Affect	NN	B-NP	O
restricted	restrict	VBD	B-VP	O
.	.	.	O	O

Thought	Thought	NNP	B-NP	O
content	content	NN	I-NP	O
,	,	,	O	O
denied	deny	VBD	B-VP	O
auditory	auditory	JJ	B-NP	O
hallucinations	hallucination	NNS	I-NP	O
,	,	,	O	O
visual	visual	JJ	B-NP	O
hallucinations	hallucination	NNS	I-NP	O
,	,	,	O	O
suicidality	suicidality	NN	B-NP	O
,	,	,	O	O
homicidality	homicidality	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
report	report	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
auditory	auditory	JJ	B-NP	O
and	and	CC	I-NP	O
visual	visual	JJ	I-NP	O
hallucinations	hallucination	NNS	I-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
preceding	precede	VBG	B-VP	O
the	the	DT	B-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
thought	thought	JJ	I-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
circumstantial	circumstantial	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
insight	insight	NN	I-NP	O
and	and	CC	I-NP	O
judgment	judgment	NN	I-NP	O
was	be	VBD	B-VP	O
impaired	impaired	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
oriented	orient	VBN	I-VP	O
to	to	TO	B-PP	O
place	place	NN	B-NP	O
,	,	,	O	O
name	name	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
time	time	NN	B-NP	O
.	.	.	O	O

Memory	Memory	NNP	B-NP	O
was	be	VBD	B-VP	O
3/3	3/3	CD	B-NP	O
at	at	IN	B-PP	O
0	0	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
0/3	0/3	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2/3	2/3	CD	B-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
choice	choice	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
language	language	NN	I-NP	O
was	be	VBD	B-VP	O
fluent	fluent	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
knew	know	VBD	B-VP	O
the	the	DT	B-NP	O
order	order	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
presidents	president	NNS	I-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
impression	impression	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
cognitive	cognitive	JJ	I-NP	O
exam	exam	NN	I-NP	O
including	include	VBG	B-PP	O
short-term	short-term	JJ	B-NP	O
memory	memory	NN	I-NP	O
and	and	CC	I-NP	O
concentration	concentration	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
auditory	auditory	JJ	I-NP	O
and	and	CC	I-NP	O
visual	visual	JJ	I-NP	O
hallucinations	hallucination	NNS	I-NP	O
and	and	CC	I-NP	O
delusions	delusion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
falls	fall	NNS	I-NP	O
they	they	PRP	B-NP	O
did	do	VBD	B-VP	O
recommend	recommend	VB	I-VP	O
continued	continued	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

AXIS	AXIS	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
:	:	:	O	O
Multifactorial	Multifactorial	JJ	B-NP	O
acute	acute	JJ	I-NP	O
delirium	delirium	NN	I-NP	O
and	and	CC	I-NP	O
depression	depression	NN	I-NP	O
and	and	CC	O	O
opioid	opioid	JJ	B-NP	O
abuse	abuse	NN	I-NP	O
by	by	IN	B-PP	O
history	history	NN	B-NP	O
.	.	.	O	O

AXIS	AXIS	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
:	:	:	O	O
Deferred	Defer	VBN	B-VP	O
.	.	.	O	O

AXIS	AXIS	NN	B-NP	O
III	III	CD	I-NP	O
:	:	:	O	O
Past	Past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

AXIS	AXIS	NN	B-NP	O
IV	IV	CD	I-NP	O
:	:	:	O	O
Severe	Severe	NNP	B-NP	O
.	.	.	O	O

AXIS	AXIS	NN	B-NP	O
V	V	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
treating	treat	VBG	I-VP	O
the	the	DT	B-NP	O
underlying	underlie	VBG	I-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
delirium	delirium	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
using	use	VBG	B-VP	O
Zyprexa	Zyprexa	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
p.r.n.	p.r.n.	FW	B-NP	O
Klonopin	Klonopin	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
showed	show	VBD	B-VP	O
cervical	cervical	JJ	B-NP	O
spondylosis	spondylosis	NN	I-NP	O
with	with	IN	B-PP	O
reversal	reversal	NN	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
cervical	cervical	JJ	I-NP	O
lordosis	lordosis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
fracture	fracture	NN	B-NP	O
and	and	CC	O	O
left	left	JJ	B-NP	B-protein
C4	C4	NN	I-NP	I-protein
,	,	,	O	O
C5	C5	NN	B-NP	O
foraminal	foraminal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

C1	C1	NN	B-NP	B-protein
through	through	IN	B-PP	O
C4	C4	NN	B-NP	B-protein
vertebral	vertebral	JJ	I-NP	I-protein
bodies	body	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
disc	disc	NN	I-NP	O
herniation	herniation	NN	I-NP	O
,	,	,	O	O
central	central	JJ	B-NP	O
foraminal	foraminal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
C5-C6	C5-C6	NN	B-NP	B-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
C7-T1	C7-T1	NN	I-NP	B-protein
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
root	root	NN	I-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
root	root	NN	I-NP	O
dilatation	dilatation	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
valves	valve	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
goal	goal	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
2.5	2.5	CD	B-NP	O
to	to	TO	B-PP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
became	become	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
goal	goal	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
2.5	2.5	CD	B-NP	O
to	to	TO	B-PP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
doses	dose	NNS	I-NP	O
were	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
generally	generally	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
between	between	IN	B-PP	O
3.5	3.5	CD	B-NP	O
and	and	CC	I-NP	O
3.75	3.75	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
to	to	TO	B-PP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
second-degree	second-degree	JJ	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
nadolol	nadolol	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
supratherapeutic	supratherapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
restarted	restart	VBD	B-VP	O
at	at	IN	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
skilled	skilled	JJ	I-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Lipitor	Lipitor	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
here	here	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mctigue	Mctigue	NNP	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
glyburide	glyburide	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
GERD	GERD	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Protonix	Protonix	NNP	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
narcotics	narcotic	NNS	I-NP	O
use	use	VBP	B-VP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
narcotic	narcotic	JJ	B-NP	O
use	use	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
taking	take	VBG	B-VP	O
a	a	DT	B-NP	O
medication	medication	NN	I-NP	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
taken	take	VBN	B-VP	O
on	on	IN	B-PP	O
10/26/06	10/26/06	CD	B-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
colonies	colony	NNS	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
pan	pan	NN	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
medication	medication	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
taken	take	VBN	I-VP	O
this	this	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
service	service	NN	I-NP	O
inhouse	inhouse	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
commented	comment	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
whole	whole	JJ	B-NP	O
body	body	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
difficulty	difficulty	NN	B-NP	O
self-medicating	self-medicate	VBG	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
.	.	.	O	O

Suggested	Suggest	VBN	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
environment	environment	NN	I-NP	O
where	where	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
starting	start	VBG	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
Cymbalta	Cymbalta	NNP	B-NP	O
,	,	,	O	O
generic	generic	JJ	B-NP	O
name	name	NN	I-NP	O
is	be	VBZ	B-VP	O
duloxetine	duloxetine	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
starting	start	VBG	I-VP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
and	and	CC	O	O
titrating	titrate	VBG	B-VP	O
up	up	RP	B-PRT	O
gradually	gradually	RB	B-ADVP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
Lidoderm	Lidoderm	NNP	I-NP	O
patch	patch	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tender	tender	NN	I-NP	O
area	area	NN	I-NP	O
holding	holding	NN	I-NP	O
narcotics	narcotic	NNS	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
happy	happy	JJ	B-ADJP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
again	again	RB	B-ADVP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
66	66	CD	B-NP	O
to	to	TO	B-PP	O
72	72	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
96	96	CD	B-NP	O
to	to	TO	B-PP	O
110/60	110/60	CD	B-NP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
-98	-98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
L.	L.	NNP	I-NP	O
General	General	NNP	I-NP	O
:	:	:	O	O
Well	Well	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
.	.	.	O	O

Loud	Loud	JJ	B-NP	O
mechanical	mechanical	JJ	I-NP	O
click	click	NN	I-NP	O
.	.	.	O	O

2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
about	about	IN	B-NP	O
8	8	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABORATORIES	LABORATORIES	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
91	91	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
43	43	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
11	11	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
181	181	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.1	9.1	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
level	level	NN	I-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
5.96	5.96	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
35.1	35.1	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
252	252	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
3.5	3.5	CD	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
51.9	51.9	CD	I-NP	I-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
additional	additional	JJ	I-NP	O
doses	dose	NNS	I-NP	O
starting	start	VBG	B-VP	O
this	this	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
8/21/06	8/21/06	CD	B-NP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
levels	level	NNS	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
holding	holding	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
below	below	IN	B-PP	O
100	100	CD	B-NP	O
or	or	CC	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
below	below	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
timolol	timolol	NN	B-NP	O
maleate	maleate	NN	I-NP	O
0.25	0.25	CD	B-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Pepto-Bismol	Pepto-Bismol	NN	B-NP	O
suspension	suspension	NN	I-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
tramadol	tramadol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Zyprexa	Zyprexa	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
agitation	agitation	NN	I-NP	O
,	,	,	O	O
latanoprost	latanoprost	RB	B-NP	O
one	one	CD	I-NP	O
drop	drop	NN	I-NP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
brimonidine	brimonidine	NN	B-NP	O
tartrate	tartrate	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Zydis	Zydis	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
sublingual	sublingual	JJ	B-ADJP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Lidoderm	Lidoderm	NN	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
patch	patch	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
upset	upset	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
duloxetine	duloxetine	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENT	APPOINTMENT	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Moxham	Moxham	NNP	I-NP	O
on	on	IN	B-PP	O
1/26/06	1/26/06	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
need	need	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Harken	Harken	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
arrange	arrange	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
going	go	VBG	I-VP	O
to	to	TO	B-PP	O
Ma	Ma	NNP	B-NP	O
Mainery	Mainery	NNP	I-NP	O
Ieldstrict	Ieldstrict	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Minnesota	Minnesota	NNP	I-NP	O
TO	TO	NNP	I-NP	O
DO	DO	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
:	:	:	O	O
Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
2.5	2.5	CD	B-NP	O
to	to	TO	I-NP	O
3.5	3.5	CD	I-NP	O
prefer	prefer	VBP	B-VP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
mechanical	mechanical	JJ	I-NP	O
valves	valve	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
daily	daily	JJ	B-NP	O
INR	INR	NN	I-NP	O
checks	check	NNS	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
steady	steady	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
likely	likely	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
3.5	3.5	CD	B-NP	O
to	to	TO	I-NP	O
3.75	3.75	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
,	,	,	O	O
she	she	PRP	B-NP	O
needs	need	VBZ	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
eight	eight	CD	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
duloxetine	duloxetine	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-9865696	5-9865696	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Manci	Manci	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Shingwa	Shingwa	NNP	I-NP	O
Rich	Rich	NNP	I-NP	O
Sterlka	Sterlka	NNP	I-NP	O
,	,	,	O	O
Oklahoma	Oklahoma	NNP	B-NP	O
23855	23855	CD	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DESTRO	DESTRO	NN	B-NP	O
,	,	,	O	O
GARLAND	GARLAND	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
EVANGELISTA	EVANGELISTA	NNP	B-NP	O
,	,	,	O	O
OLLIE	OLLIE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9357080	9357080	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/21/06	8/21/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/21/06	8/21/06	CD	B-NP	O

